Century Therapeutics, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Century Therapeutics, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $109.16 million for the year ending 2025.

  • Century Therapeutics, Inc. showed an increase of +1,556.8% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
  • This data is from Century Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), Century Therapeutics, Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 1,999.7%.
  • Historical annual values: Fiscal year 2025: $109.16 million | Fiscal year 2024: $6.59 million | Fiscal year 2023: $2.24 million | Fiscal year 2022: $5.20 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: